There is a need to explore the common indications for contrast-enhanced liver MRI. In order to do this, our faculty will review characteristics and safety profiles of the currently available GBCAs including discussing the differences between extracellular and hepatobiliary GBCA options. The purpose of this webinar is to provide physicians, technologists, and other health care professionals with current clinical data to make informed decisions in their clinical settings.
-
- Review the characteristics and safety profile of the currently available Gd-based contrast agents (GBCA) for MR liver imaging.
- Understand the differences between extracellular and hepatobiliary GBCA
- Explore the common indications for contrast-enhanced liver MRI
- Discuss GBCA enhanced MRI of the liver in both non-cirrhotic and non-oncologic patients.
The content of this CME/CE webinar is intended for healthcare professionals including Radiologists and Other Physicians, Technologists, Radiologic and Imaging Nurses, Facility Managers, Researchers, and others.
This program has been submitted for 1.5 hours of Category A CE ARRT credit, as designated by The International Society for MR Radiographers & Technologists (ISMRT) RCEEM. This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat an activity for credit if it was reported in the same or any subsequent biennium.
Release Date: 02/02/2022 | Expires 02/01/2023
Faculty and Planner Disclosures:
As an accredited provider of continuing medical education, it is the policy of Northwest Imaging Forums, Inc. (NWIF) to ensure balance, independence, objectivity, and scientific rigor in all of its activities. In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME activity. The planner has nothing to disclose.
Jeffrey Maki MD, PhD
- Bracco Diagnostics Inc.
Alessandro Furlan, MD
- Enrda Life Sciences
Jeffrey Maki MD, PhD
Director MRI & Nuclear Brain Imaging
Professor of Radiology Chief of Abdominal Imaging
University of Colorado Anschutz
Medical Center Denver, Colorado
Alessandro Furlan MD
Associate Professor Chief – Abdominal
Imaging Division Department of Radiology
University of Pittsburgh
Medical Center
Pittsburgh, Pennsylvania